Download video

The potential role of TIGIT/LAG-3 inhibition in urothelial carcinoma

39 views

VJOncology

8 months ago

The potential role of TIGIT/LAG-3 inhibition in urothelial carcinoma

The potential role of TIGIT/LAG-3 inhibition in urothelial carcinoma

The potential role of TIGIT\/LAG-3 inhibition in urothelial carcinoma
1:12
The potential role of TIGIT\/LAG-3 inhibition in urothelial carcinoma
by VJOncology
Daniel Petrylak, MD, discusses the role of checkpoint inhibition therapy in urothelial carcinoma
3:03
Daniel Petrylak, MD, discusses the role of checkpoint inhibition therapy in urothelial carcinoma
by OBRoncology
Upcoming therapies in the metastatic urothelial carcinoma space
4:00
Upcoming therapies in the metastatic urothelial carcinoma space
by VJOncology
Should PD-L1 be used as a biomarker for immunotherapy in bladder cancer?
2:41
Should PD-L1 be used as a biomarker for immunotherapy in bladder cancer?
by VJOncology
The evolving role of antibody-drug conjugates in the treatment of urothelial carcinoma
31:39
The evolving role of antibody-drug conjugates in the treatment of urothelial carcinoma
by Touch Medical Media
Management of BCG Unresponsive Cystectomy Ineligible Bladder Cancer Patients Pembrolizumab
10:35
Management of BCG Unresponsive Cystectomy Ineligible Bladder Cancer Patients Pembrolizumab
by Grand Rounds in Urology
Earlier Use of Immune Checkpoint Inhibitors to Adjuvant and Non Muscle Invasive Bladder Cancer
10:44
Earlier Use of Immune Checkpoint Inhibitors to Adjuvant and Non Muscle Invasive Bladder Cancer
by Grand Rounds in Urology
The future role of erdafitinib in advanced urothelial carcinoma
1:47
The future role of erdafitinib in advanced urothelial carcinoma
by VJOncology
FGFR3 Inhibitors for Upper Tract Urothelial Cancer
6:24
FGFR3 Inhibitors for Upper Tract Urothelial Cancer
by Grand Rounds in Urology
Role of vaccines in urothelial carcinoma
0:50
Role of vaccines in urothelial carcinoma
by VJOncology
2.22.2021 Urology COViD Didactics - Immunotherapy for Bladder Cancer
55:15
2.22.2021 Urology COViD Didactics - Immunotherapy for Bladder Cancer
by Urology COViD
Key clinical trials in urothelial carcinoma at ESMO 2021
1:22
Key clinical trials in urothelial carcinoma at ESMO 2021
by VJOncology
Current and upcoming treatment strategies for upper tract urothelial cancer
0:57
Current and upcoming treatment strategies for upper tract urothelial cancer
by VJOncology
Immune checkpoint inhibitors in urothelial bladder cancer
2:01
Immune checkpoint inhibitors in urothelial bladder cancer
by VJOncology
Bladder Cancer: Understanding Immune-, Targeted-, and Antibody-Based Models for Patient Care
1:03:24
Bladder Cancer: Understanding Immune-, Targeted-, and Antibody-Based Models for Patient Care
by PeerView Oncology
The evolving treatment landscape of advanced and metastatic urothelial carcinoma
2:05
The evolving treatment landscape of advanced and metastatic urothelial carcinoma
by VJOncology
Role of Checkpoint Inhibition for Localized Bladder Cancer
2:35
Role of Checkpoint Inhibition for Localized Bladder Cancer
by PracticeUpdate
The role of erdafitinib in treating patients with bladder cancer
2:20
The role of erdafitinib in treating patients with bladder cancer
by VJOncology
Urothelial Cancer \& Emerging Role of Immunotherapy
5:50
Urothelial Cancer \& Emerging Role of Immunotherapy
by Mayo Proceedings
Petros Grivas, ESMO 2019 - Advances in metastatic urothelial cancer
9:10
Petros Grivas, ESMO 2019 - Advances in metastatic urothelial cancer
by Touch Medical Media